Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma.

Acta Neuropathologica Communications
M-M GeorgescuD K Burns

Abstract

Diffuse midline gliomas (DMGs) are aggressive pediatric brain tumors with dismal prognosis due to therapy-resistant tumor growth and invasion. We performed the first integrated histologic/genomic/proteomic analysis of 21 foci from three pontine DMG cases with supratentorial dissemination. Histone H3.3-K27M was the driver mutation, usually at high variant allele fraction due to recurrent chromosome 1q copy number gain, in combination with germline variants in ATM, FANCM and MYCN genes. Both previously reported and novel recurrent copy number variations and somatic pathogenic mutations in chromatin remodeling, DNA damage response and PI3K/MAPK growth pathways were variably detected, either in multiple or isolated foci. Proteomic analysis showed global upregulation of histone H3, lack of H3-K27 trimethylation, and further impairment of polycomb repressive complex 2 by ASXL1 downregulation. Activation of oncogenic pathways resulted from combined upregulation of N-MYC, SOX2, p65/p50 NF-κB and STAT3 transcription factors, EGFR, FGFR2, PDGFRα/β receptor tyrosine kinases, and downregulation of PHLPP1/2, PTEN and p16/INK4A tumor suppressors. Upregulation of SMAD4, PAI-1, CD44, and c-SRC in multiple foci most likely contributed to invasi...Continue Reading

References

Nov 1, 1992·European Journal of Biochemistry·T HagiwaraY Taya
Jul 1, 1993·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·G P Zambetti, A J Levine
Apr 1, 1997·The Journal of Pathology·B Radotra, D McCormick
Jan 1, 1997·Human Mutation·M UpadhyayaP S Harper
Sep 26, 2001·The Journal of Biological Chemistry·S BurmaD J Chen
May 3, 2003·Cancer Cell·Selma PennacchiettiPaolo M Comoglio
Jul 15, 2003·Clinical & Experimental Metastasis·G O HjortlandO Engebraaten
Sep 2, 2003·Neuron·Victoria GrahamLarysa Pevny
Feb 4, 2006·The EMBO Journal·Yoko TakahashiMaria-Magdalena Georgescu
Sep 5, 2006·Molecular Cell·Sathyavageeswaran ShreeramDmitry V Bulavin
Dec 13, 2006·The Journal of Experimental Medicine·Sathyavageeswaran ShreeramDmitry V Bulavin
Dec 29, 2007·The Journal of Biological Chemistry·Tianyan GaoAlexandra C Newton
Feb 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maryam ZarghooniCynthia Hawkins
Jun 22, 2010·Neoplasia : an International Journal for Oncology Research·Jennifer R MolinaMaria-Magdalena Georgescu
Apr 19, 2011·Nature Genetics·Xiaomu WeiYardena Samuels
Sep 21, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Barbara S PaughSuzanne J Baker
Dec 3, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Marko KornmannKarl-Heinrich Link
Jan 31, 2012·Nature Genetics·Gang WuUNKNOWN St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project
Jun 6, 2013·British Journal of Cancer·M Katoh
Aug 24, 2013·Cancer Research·Barbara S PaughSuzanne J Baker
Feb 21, 2014·Oncotarget·Nitin Kumar AgarwalMaria-Magdalena Georgescu
Sep 19, 2014·Nature Reviews. Cancer·Chris Jones, Suzanne J Baker
Oct 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Johanna I KiiskiHeli Nevanlinna
Mar 17, 2015·Chromosoma·Satish KallappagoudarJanet F Partridge
Mar 17, 2015·Acta Neuropathologica Communications·Maria-Magdalena GeorgescuJack M Raisanen
Jun 13, 2015·Nature Communications·Karim LabrecheUNKNOWN POLA Network
Dec 8, 2015·Acta Neuropathologica Communications·Maria-Magdalena GeorgescuDennis K Burns

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
biopsy
biopsies
electrophoresis
X-ray
acetylation

Software Mentioned

GraphPad Prism
GraphPad
Image Lab

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Related Papers

Journal of Neuro-oncology
Tabitha M CooneySabine Mueller
Journal of Child Neurology
Tammy Hennika, Oren J Becher
Journal of Neurosurgery. Pediatrics
Ira J Dunkel, Mark M Souweidane
Australasian Radiology
W T McCoy
© 2021 Meta ULC. All rights reserved